Bank of Montreal
CORV

Bank of Montreal’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bank of Montreal’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-300
Closed -$1K – 5187
2019
Q1 		$1K Sell
300
-204
-40% -$660 ﹤0.01% 4249
2018
Q4 		$2K Hold
504
– – ﹤0.01% 4477
2018
Q3 		$2K Hold
504
– – ﹤0.01% 4450
2018
Q2 		$2K Hold
504
– – ﹤0.01% 4458
2018
Q1 		$1K Hold
504
– – ﹤0.01% 4130
2017
Q4 		$0 Sell
504
-500
-50% -$803 ﹤0.01% 4418
2017
Q3 		$2K Buy
1,004
+204
+26% +$694 ﹤0.01% 4064
2017
Q2 		$4K Sell
800
-5,952
-88% -$21.6K ﹤0.01% 3923
2017
Q1 		$20K Hold
6,752
– – ﹤0.01% 3373
2016
Q4 		$18K Hold
6,752
– – ﹤0.01% 3433
2016
Q3 		$22K Hold
6,752
– – ﹤0.01% 3317
2016
Q2 		$34K Buy
6,752
+300
+5% +$1.44K ﹤0.01% 3188
2016
Q1 		$26K Sell
6,452
-125
-2% -$669 ﹤0.01% 3304
2015
Q4 		$53K Buy
6,577
+5,929
+915% +$49.4K ﹤0.01% 3023
2015
Q3 		$5K Sell
648
-363
-36% -$3.34K ﹤0.01% 3662
2015
Q2 		$10K Sell
1,011
-5
-0.5% -$47 ﹤0.01% 3504
2015
Q1 		$10K Sell
1,016
-6
-0.6% -$57 ﹤0.01% 3506
2014
Q4 		$10K Sell
1,022
-8
-0.8% -$67 ﹤0.01% 3559
2014
Q3 		$9K Buy
1,030
+530
+106% +$3.86K ﹤0.01% 3694
2014
Q2 		$4K Sell
500
-20
-4% -$151 ﹤0.01% 4310
2014
Q1 		$4K Buy
520
+20
+4% +$161 ﹤0.01% 3843
2013
Q4 		$3K Hold
500
– – ﹤0.01% 3608
2013
Q3 		$2K Sell
500
-180
-26% -$409 ﹤0.01% 3689
2013
Q2 		$1K Buy
+680
New +$1.36K ﹤0.01% 3619

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Bank of Montreal's CORV Position: Q2 2019 in Review

Bank of Montreal sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2019, closing a stake of 300 shares — an estimated $1K sold.

Bank of Montreal first reported a position in CORV in Q2 2013 and held it in 24 quarters. The position peaked at $53K in Q4 2015. 36 funds tracked by Wall St. Rank hold CORV as of Q2 2019.

  • Bank of Montreal reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2019 after selling out during the quarter.
  • Bank of Montreal sold 300 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2019, an estimated $1K.
  • Bank of Montreal first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 24 quarters.
  • Bank of Montreal's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $53K in Q4 2015.
  • 36 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.